title: Physiology and molecular biology of multidrug resistance in Entamoeba histolytica.
abstract: In this paper, we present the most relevant facts on multidrug resistance (MDR) in the protozoan parasite Entamoeba histolytica. MDR in E. histolytica presents characteristics similar to transformed mammalian cells. E. histolytica drug resistant mutants show cross-resistance to several drugs, and as in mammalian cells the resistance is reverted by verapamil. Six P-glycoprotein-like genes (EhPgp) have been cloned and characterized. Apparently, four of these genes are transcribed in drug-resistant mutants (EhPgp1, EhPgp2, EhPgp5 and EhPgp6), although only EhPgp1, EhPgp5 and EhPgp6 transcripts were clearly detected. The open reading frame (ORF) of the four completely full length genes is about 1300 amino acids long. EhPgp1, EhPgp2 and EhPgp5 have between 64 and 67% of positional identity among them, while EhPgp6 shows 38 to 46% positional identity to the other ameba genes. Interestingly, the phylogenetic tree suggested that Entamoeba P-glycoproteins are more related to the human and mouse P-glycoproteins than to the Plasmodium and Leishmania P-glycoproteins. Differential gene expression in drug-resistant mutants was detected when specific probes for each Ehpgp gene were used. To understand the differential expression of EhPgp genes we initiated the characterization of the upstream flanking regions of EhPgp1 and EhPgp5 genes. Upstream sequences showed between 53 and 66% of positional identity to Dictyostelium discoideum promoters.
authors.affiliation: Departamento de Patología Experimental, Centro de Investigación y de Estudios Avanzados del I.P.N., México, D.F.
authors.forename: M D
authors.initials: MD
authors.lastname: Gómez
authors.forename: D G
authors.initials: DG
authors.lastname: Pérez
authors.forename: P
authors.initials: P
authors.lastname: Ayala
authors.forename: J
authors.initials: J
authors.lastname: Samuelson
authors.forename: E
authors.initials: E
authors.lastname: Orozco
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics; D000563:Amebicides / Q000494:pharmacology*; D000818:Animals; D001483:Base Sequence; D003078:Colchicine / Q000378:metabolism; D016384:Consensus Sequence; D018432:Drug Resistance, Multiple / Q000235:genetics / Q000502:physiology*; D004748:Entamoeba histolytica / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D017125:Genes, Protozoan; D006801:Humans; D007891:Leishmania / Q000235:genetics; D051379:Mice; D008969:Molecular Sequence Data; D016366:Open Reading Frames; D010802:Phylogeny; D010961:Plasmodium / Q000235:genetics; D015800:Protozoan Proteins / Q000235:genetics* / Q000502:physiology; D012333:RNA, Messenger / Q000096:biosynthesis; D016053:RNA, Protozoan / Q000096:biosynthesis; D016415:Sequence Alignment; D012689:Sequence Homology, Nucleic Acid; D013045:Species Specificity; D014700:Verapamil / Q000378:metabolism
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000563:Amebicides; D015800:Protozoan Proteins; D012333:RNA, Messenger; D016053:RNA, Protozoan; D014700:Verapamil; D003078:Colchicine